Abstract
Growth of the murine hepatoma H6 was significantly suppressed by amiloride, a sodium influx inhibitor. Primary tumor growth inhibition was augmented by loading the drug into cross-linked albumin carriers, but lung metastases were enhanced. These results emphasize the importance of using metastatic tumor models when testing new drugs and/or alternative modes of drug delivery.
Original language | English (US) |
---|---|
Pages (from-to) | 63-70 |
Number of pages | 8 |
Journal | Clinical and Experimental Metastasis |
Volume | 4 |
Issue number | 1 |
DOIs | |
State | Published - Mar 1986 |
ASJC Scopus subject areas
- Oncology
- Cancer Research